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Article Information  ABSTRACT 
Received:  23rd October 2020  The aim of the current review is to acquaint all the covering aspect of dibetes mellitus which can provide 
awareness to the diabetes patients in india as well as all over the world. The number of diabetic patients 
in india is increasing at an alarming rate and is therefore a major area for concern. As per the WHO, 
the diabetes is expected to reach 79.4 million by 2030. The studies have shown that the type II diabetes 
is 4-6 times higher in urban than in rural areas in india. Development of  diabetes among indians is due 
to several factors such as age ( Based on NHANES data),waist circumference, hypertention, BMI, 
smoking habit and total cholestero these variables are important for comparing diabetic and non-
diabetic patients 
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INTRODUCTION 
Diabetes mellitus is probably one of the oldest diseases known 
to man. It was first reported in Egyptian manuscript about 3000 
years ago [1]. The diabetes is derived from Greek word i.e. 
‘Siphon’ (to pass through) and the term Mellitus was added to 
diabetes in 1675 by Thomas. The mellitus word was derived 
from Latin term i.e. honeyed or sweet [2]. Diabetes mellitus is a 
metabolic illness caused by abnormalities in insulin secretion, 
insulin action, or both. It is characterized by persistent 
hyperglycemia and problems in carbohydrate, lipid, and protein 
metabolism.[3][4]. In India, the diabetes is commonly known as 
‘Madhumeha’( honey urine) because it attracts ants[5].      
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Type 1 diabetes is assumed to be caused by the loss of insulin-
producing pancreatic cells that is immune-mediated, if not 
directly immune-mediated. Insulin pumps and continuous 
glucose monitors have improved, making it easier for patients 
with type 1 diabetes to manage the burden of lifetime insulin 
administration [6][7]. Type 2 diabetes mellitus (T2DM) is a 
global epidemic associated with increased health expenditure, 
and low quality of life. Many non-genetic risk factors have been 
suggested, but their overall epidemiological credibility has not 
been assessed [8]. Type 3 diabetes” accurately reflects the fact 
that AD represents a form of diabetes that selectively involves 
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the brain and has molecular and biochemical features that 
overlap with both type 1 diabetes mellitus and T2DM [9][10]. 
Type 4 DM may be a new term that is still not standard. 
Nevertheless, type 4 DM is likely to exist and it might be under 
recognized. It has been found in the ongoing research that this 
type of diabetes is completely different from the one 
accompanied by the high blood glucose levels [11]. 
 
EPIDEMIOLOGY 
Several facts contribute to augmented diabetes epidemic, such 
as “normal-weight metabolically obese” phenotype; high intake 
of refined carbohydrates; excess consumption of alcohol and 
extensive smoking and frequent reduction of physical activities 
or exercise Underprivileged nutrition in utero as well as in initial 
life collective with over nutrition in later life may 
correspondingly play a role in diabetes epidemic[12][13].The 
Identification of the cause of disease and the possible preventive 
measures that could be instituted to arrest or delay the onset of 
this disease which has reached epidemic proportions in both the 
developed and the developing nations. Unfortunately, the 
improvement in outcomes for individual patients with diabetes 




When Banting, Best, Collip, and Macleod used a chemical 
isolated from bovine pancreas to successfully reduce blood 
glucose levels and glycosuria in a patient in the 1920s. Clinical 
data in the mid-1930s, however, showed a possible 
differentiation between insulin-sensitive and insulin-insensitive 
diabetes. It wasn't until the 1950s, when a reliable measure of 
circulating insulin became available, that these clinical 
observations could be translated into pathophysiological and 
biochemical distinctions. The next 30 years were marked by 
significant advances in immunology, which were crucial in 
revealing an immune-mediated loss of insulin-secreting -cells in 
patients with ‘insulin-dependent' diabetes, as well as novel 
experimental techniques for measuring insulin ‘impedance' 
showed a Insulin's peripheral action was diminished in non-
insulin-dependent diabetes patients (insulin resistance). 
 
The distinction between the two forms of diabetes was formally 
recognized in 1979, when the labels "type I" and "type II" 
diabetes were used to replace the words "insulin-dependent" and 
"non-insulin-dependent.’’[16][17][18].  
The key pathophysiological hallmarks of type 2 diabetes, 
impaired insulin production and increased insulin resistance, 
work together to promote the disease's progression. Various 
environmental factors, added to these genetic factors, are 
considered responsible for the onset of disease, and the number 
of patients is increasing rapidly reflecting recent lifestyle 
changes. Impaired insulin secretion is characterized by lowered 
glucose responsiveness. Lowered glucose response is a 
symptom of impaired insulin secretion. The decrease in 
postprandial-phase secretion, in particular, is an important 
pathological condition [19][20]. 
 
RISK ASSESSMENT 
The various factors influencing diabetes mellitus are genetic, 
pathophysiological, environment and lifestyle. The human 
leukocyte antigen (HLA) class II genes in chromosome 6, and 
more than 40 other than non-HLA genetic markers are being 
confirmed for the main susceptibility region for type I diabetes. 
Apart from type I diabetes the type II diabetes is a complex 
genetic disease along with strong environmental triggers, 
metabolic conditions which are all related to glucose intolerance 
resulting damage to insulin secretion.  
 
Obesity is also considered a major factor for type II diabetes 
because overweight leads to higher cardiovascular risk. The diet 
of an individual also influence the optimal levels of blood 
glucose level. Sedentary lifestyle is considered the most 
prominent factors for type II diabetes. Physical activity gives 
positive effects on muscle growth, muscle glucose utilization, 
insulin liver sensitivity and overall glycemic control 
[21][22][23]. 
 
All types of diabetes mellitus have something in common. When 
you eat carbohydrates and sugars, they are converted into 
glucose.  The cells in body are fueled by glucose. But the cells 
use glucose for energy and the cells need insulin, a hormone, in 
your bloodstream [24][25]. According to the International 
Diabetes Federation (IDF), the global population with diabetes 
between the ages of 20 and 79 was 285 million (6.4 percent) in 
2010, and it is expected to rise to 439 million (7.7%) by 2030. 
According to the 6th edition of the Diabetes Atlas, there were 
382 million diabetics in the globe in 2013, with that number 
expected to climb to 592 million (80 percent) by 2035[26][27]. 
Diabetes can only be regulated with various type of medicines 
along with exercise or yoga therapy or diet plan. Insulin 
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treatment is generally performed in type I diabetes mellitus and 
other oral hypoglycemic drug such as sulphonylureas, 
thiazolidinediones, peptide analogs are used for treatment of 
type II diabetes mellitus. According to world ethanobotanical 
800 medicinal plants are used for the prevention of diabetes 
mellitus. However only 450 medicinal plants have been 
clinically proven to have anti diabetic property from which 109 
medicinal plant have complete mode of action[28][29][30]. Age 
group (45–69  years), marital status, hypertension, obesity and 
family history of DM were found to be the risk factors 
significantly associated with DM in a multivariate regression 
model in Punjab, India [31][32]. Transdermal medication 
administration is gaining popularity these days due to its 
advantages over traditional oral dose forms. By 2025, the global 
transdermal medication delivery system market is expected to 
expand to around 95.57 billion dollars [33][34].  
 
DIAGNOSIS 
Diabetes mellitus is diagnosed using either the estimation of 
plasma glucose or HbA1C. The association of fasting plasma 
glucose of 126 mg/dL (7.0 mool/L), plasma glucose after 2 hours 
OGTT (oral glucose tolerance test) of 200 mg/dL (11.1 mool/L), 
HbA1C of 6.5 percent (48 mmol/mol), or a random plasma 
glucose of 200 mg/dL or 11.1 mmol/L) along with symtoms of 
hyperglycemia is diagnostic of diabetes mellitus [35][36].  
 
TREATMENT USING HERBAL DRUGS 
Diabetes mellitus is becoming a common metabolic disorder 
which has serious threat to public health in the world. There are 
chemicals and biochemical agent that helps in controlling 
diabetes but there is no permanent remedy available which helps 
to get recover are completely from this disorder 9. Herbal 
medications and plants are utilized in the treatment of diabetes 
in India.  
 
While there are several techniques to reducing the negative 
consequences of diabetes, herbal formulations are favored since 
they have less side effects and are less expensive. The following 
are the proven antidiabetic and herbal medications used in the 
treatment of diabetes. Momordica charantia, Allium sativum, 
Eugenia jambolana Ocimum sanctum, Phyllanthus amarus, 
Pterocarpus marsupium, Tinospora cordifolia, Trigonella 
foenum graecum, and Withania somnifera are some of the plants 
that grow in this area [37][38][39]. 
 
CONCLUSION 
Despite the lack of concrete epidemiological evidence, it is both 
intellectually and medically valid to consider a historical 
reframing of diabetes in India. All diabetic patients should 
remember a simple strategy for preventing such type of chronic 
disorder and that is the Mantras regular exercise, less intake of 
food and avoid such ante food which can be harmful 
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